AbCellera Biologics Inc. Quarterly Nonoperating Income (Expense) in USD from Q1 2020 to Q4 2024

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
AbCellera Biologics Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from Q1 2020 to Q4 2024.
  • AbCellera Biologics Inc. Nonoperating Income (Expense) for the quarter ending December 31, 2024 was $25.9M, a 48.5% increase year-over-year.
  • AbCellera Biologics Inc. Nonoperating Income (Expense) for the twelve months ending December 31, 2024 was $114M, a 81% increase year-over-year.
  • AbCellera Biologics Inc. annual Nonoperating Income (Expense) for 2024 was $114M, a 81% increase from 2023.
  • AbCellera Biologics Inc. annual Nonoperating Income (Expense) for 2023 was $63.2M, a 180% increase from 2022.
  • AbCellera Biologics Inc. annual Nonoperating Income (Expense) for 2022 was $22.6M, a 53.3% increase from 2021.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q4 2024 $114M $25.9M +$8.47M +48.5% Oct 1, 2024 Dec 31, 2024 10-K 2025-02-27
Q3 2024 $106M $31M +$15.4M +98.7% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-04
Q2 2024 $90.5M $45.3M +$31.9M +238% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-06
Q1 2024 $58.6M $12.1M -$4.58M -27.4% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-07
Q4 2023 $63.2M $17.5M +$11.1M +174% Oct 1, 2023 Dec 31, 2023 10-K 2025-02-27
Q3 2023 $52.1M $15.6M +$6.76M +76.4% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-04
Q2 2023 $45.3M $13.4M +$11.9M +786% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-06
Q1 2023 $33.5M $16.7M +$10.9M +185% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-07
Q4 2022 $22.6M $6.37M +$3.13M +96.6% Oct 1, 2022 Dec 31, 2022 10-K 2025-02-27
Q3 2022 $19.5M $8.85M +$5.73M +183% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-02
Q2 2022 $13.7M $1.51M -$3.45M -69.6% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-03
Q1 2022 $17.2M $5.86M +$2.45M +71.7% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-04
Q4 2021 $14.7M $3.24M +$8.1M Oct 1, 2021 Dec 31, 2021 10-K 2024-02-20
Q3 2021 $6.64M $3.12M +$4.05M Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-08
Q2 2021 $2.59M $4.96M -$2.6M -34.4% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-09
Q1 2021 $5.19M $3.41M +$3.38M +11669% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-10
Q4 2020 $1.8M -$4.86M Oct 1, 2020 Dec 31, 2020 10-K 2023-02-21
Q3 2020 -$925K Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-10
Q2 2020 $7.56M Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-13
Q1 2020 $29K Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.